View Clinical Trial (Medical Research Study)
Behavioral Science Aspects of Rapid Test Acceptance
| City: |
|
Long Beach |
| State: |
|
California |
| Zip Code: |
|
90813 |
| Conditions: |
|
HIV - Hepatitis C - Hepatitis B - Syphilis |
| Purpose: |
|
The relevance of this research to public health is to make it possible to test for hepatitis
C and syphilis at point of care so that people will receive their results immediately
instead of requiring people to wait for at least a week to get their test results. This
research will make rapid tests for HIV available that can detect HIV infection earlier and
are more accurate than current tests available in the United States.
|
| Study Summary: |
|
This application addresses "Studies to improve access and utilization of HIV counseling and
testing" for "HIV/AIDS and AIDS-related co-infections" such as "hepatitis C virus (HCV),
other sexually transmitted infections (STIs)" that are part of PA-07-307 Drug Abuse Aspects
of HIV/AIDS. The only rapid tests that are approved for use in the US currently are for HIV
infection. Tests for other conditions such as hepatitis C (HCV) and syphilis are in use in
other countries. In response to an Opportunity that the CDC published in the Federal
Register, there are now candidate rapid test kits for HCV and syphilis available for
experimental use in the US. Different combinations of rapid and standard tests will be
offered to participants in a four-arm trial to assess which tests are accepted by the
participants. Only a minority of clients at CBRS who have been offered the rapid test for
HIV have accepted it. Those who chose rapid HIV tests were more likely to be male, educated,
gay, young and White. They were less likely to be Black, or injection drug users. The
proposed study has the potential to have a significant impact upon screening for HIV,
syphilis, and HCV. Rapid tests have the potential to increase the receipt of test results,
particularly among groups that are less likely to return for their results using traditional
testing. The candidate tests are designed for Point of Care (either oral fluid and/or whole
blood), and thus will require real-time testing, so the trial will be able to evaluate both
the accuracy of the tests in settings of intended use and their acceptability to potential
clients in real-world situations.
|
| Criteria: |
|
Inclusion Criteria:
- Over 17 years old
- Mentally stable
- Sober
- Able to understand English or Spanish
- At least one good vein for phlebotomy
- Member of Behavioral Risk Group
|
| NCT ID: |
|
NCT01317784 |
| Primary Contact: |
|
Principal Investigator
Dennis G Fisher, Ph.D.
California State University, Long Beach
Grace L Reynolds, D.P.A.
Phone: 562-495-2330 ext. 125
Email: Grace.Reynolds@csulb.edu
|
| Backup Contact: |
|
Email: Kristen.Hess@csulb.edu
Kristen Hess, Ph.D.
Phone: 562-495-2330 ext. 111
|
| Location Contact: |
|
Long Beach, California 90813
United States
There is no listed contact information for this specific location.
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 21, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|